Immuno-Oncology

conference reporter

by Bruce E. Johnson, MD

At the 2022 ASCO Annual Meeting, data from clinical trials pointed to an expanding role of immune checkpoint inhibitor (ICI) therapy for several so......READ MORE

conference reporter

by Mark G. Kris, MD

Data from the 2022 ASCO Annual Meeting illustrate the great potential of immune checkpoint inhibitor (ICI) therapy in subsets of patients with soli......READ MORE

conference reporter

by Mark G. Kris, MD

As seen at the 2022 ASCO Annual Meeting, researchers continue to work toward a better understanding of the complexity and sophistication of the imm......READ MORE

conference reporter

by Julie R. Brahmer, MD, MSc

Immuno-oncology has transformed the treatment paradigm across multiple tumor types and histologies. Proceedings from the 2022 ASCO Annual Meeting h......READ MORE

conference reporter

by Julie R. Brahmer, MD, MSc

At the 2022 ASCO Annual Meeting, several studies highlighted the promise of combination strategies and the optimal incorporation of immune checkpoi......READ MORE